CLSA Objectives

The CLSA is currently in its third phase of funding (2021-2027). The specific objectives for the CLSA Phase III are:

• Continued implementation of the approved CLSA protocol, including two waves of data collection for the tracking and comprehensive cohorts, analysis of a core set of biomarkers and continued optimization of participant retention for a robust longitudinal cohort;
• Ongoing optimization of systems and mechanisms, including a communication and outreach strategy (that includes a data promotion plan) that will ensure responsible and timely access to high quality CLSA data and biospecimens, while meeting ethical standards and protecting the privacy of CLSA participants; and
• Continued evolution of the CLSA governance structure and business model to ensure long-term stability and sustainability of the platform and its related operations. This should include governance and decision-making, management and operating plans, succession planning, and strategies for partnership and collaboration that continue to position the platform as a world-class scientific resource.

Date modified:

2024-08-12